SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000905718-20-000111
Filing Date
2020-02-10
Accepted
2020-02-10 16:50:59
Documents
2
Group Members
ABINGWORTH BIOVENTURES VII, LP

Document Format Files

Seq Description Document Type Size
1 SIERRA 13D sierraonc_13djan292020.htm SC 13D 69638
2 JOINT FILING EXHIBIT 1 sierraonc_13dexh1.htm EX-1 9293
  Complete submission text file 0000905718-20-000111.txt   80517
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Subject) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89009 | Film No.: 20592611
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D